The FDA's OTC Hearing Aid Rule: What Changed in 2022

On October 17, 2022, a new era in American hearing healthcare officially began. The U.S. Food and Drug Administration (FDA) finalized a rule that created a new regulatory category: over-the-counter (OTC) hearing aids. This landmark change allowed adults with mild-to-moderate hearing loss to purchase hearing aids directly - without a prescription, without a medical exam, and without a fitting appointment - from retail stores and online platforms. Here is what the rule does, why it matters, and what it means for you.

What Was the Problem Before 2022?

Before the FDA's OTC rule took effect, all hearing aids were classified as prescription medical devices. Obtaining a pair required visiting an audiologist or hearing aid dispenser, undergoing a diagnostic evaluation, and purchasing devices through that professional - a process that could take weeks and cost thousands of dollars.

The average price of a pair of prescription hearing aids ranged from $3,000 to $7,000 or more. Most health insurance plans, including traditional Medicare, did not cover hearing aids. For the tens of millions of Americans on fixed incomes - particularly older adults - this price point placed hearing aids effectively out of reach.

The result: only about one in five people who could benefit from hearing aids actually used them. The gap between prevalence of hearing loss and uptake of treatment was staggering, and cost was consistently cited as the number one barrier.

The Path to the OTC Rule

The push to create an OTC hearing aid category did not happen overnight. The Over-the-Counter Hearing Aid Act was signed into law in 2017 as part of the FDA Reauthorization Act, directing the FDA to establish a new regulatory category for OTC hearing aids within three years. The process took longer than expected - delayed in part by the COVID-19 pandemic - but the final rule was issued in August 2022 and went into effect in October of that year.

The legislation had bipartisan support and was championed by consumer advocacy groups, hearing health organizations, and economists who argued that removing prescription barriers would lower prices through competition and expand access.

What the Rule Actually Does

The FDA's OTC hearing aid rule established a new category of hearing aids specifically for adults 18 and older with mild-to-moderate hearing loss. Key provisions include:

• No prescription required: Adults can purchase OTC hearing aids directly without seeing a provider first
• No medical exam required: The rule eliminated the requirement for a medical evaluation before purchase (though it is always advisable to consult a physician if you have ear pain, drainage, sudden hearing loss, or other concerning symptoms)
• Output limits: OTC devices must comply with maximum output limits to ensure they are safe without professional fitting
• Labeling requirements: OTC hearing aids must carry specific labeling indicating they are for adults with mild-to-moderate hearing loss and include clear usage instructions
• User-controlled settings: OTC devices can be self-fitted by the user, allowing them to adjust volume and sound settings themselves

What Did Not Change

The OTC rule specifically covers adults with mild-to-moderate hearing loss. Prescription hearing aids - for those with severe or profound hearing loss, or for children - remain prescription-only products. The rule also did not eliminate audiologists or hearing care professionals; it simply created an additional pathway for people who prefer or need direct access.

The Impact on Prices

One of the most anticipated effects of the OTC rule was increased competition driving down prices. Early results are promising. OTC hearing aids now retail from as little as $99 for basic amplification devices to several hundred dollars for feature-rich OTC hearing aids with Bluetooth connectivity, app control, and noise reduction. This represents a dramatic price reduction compared to the $3,000 to $7,000 cost of traditional prescription devices.

What It Means for Consumers

For the estimated 28 to 48 million Americans with mild-to-moderate hearing loss, the OTC rule means:

• Faster access: purchase a hearing device today and start using it immediately
• Lower cost: OTC devices are a fraction of prescription hearing aid prices
• More options: a growing marketplace of devices with varying features and price points
• Greater control: self-fit and self-adjust your device to your preferences

Key Takeaways

• The FDA's OTC hearing aid rule went into effect October 17, 2022
• Adults with mild-to-moderate hearing loss can now buy hearing aids without a prescription
• OTC hearing aids are available at retail stores and online at significantly lower prices
• The rule created more access, more competition, and more affordable options
• Prescription hearing aids for severe/profound loss and for children remain unchanged

The FDA's OTC hearing aid rule is a milestone in consumer health access. If you have been waiting to address your hearing loss because of cost or complexity, the landscape has fundamentally changed - and OTC hearing aids make getting started easier than ever.